Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with Target = 'Histone acetyltransferase type B catalytic subunit'
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764596(US20250257055, Example 34 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764595(US20250257055, Example 33 | US20250263415, Example...)
Affinity DataIC50: 0.200nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764573(US20250257055, Example 10 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764594(US20250257055, Example 32 | US20250263415, Example...)
Affinity DataIC50: 0.400nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764567(US20250257055, Example 4 | US20250263415, Example ...)
Affinity DataIC50: 0.5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764566(US20250257055, Example 3 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764572(US20250257055, Example 9 | US20250263415, Example ...)
Affinity DataIC50: 0.600nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764570(US20250257055, Example 7 | US20250263415, Example ...)
Affinity DataIC50: 0.900nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764593(US20250257055, Example 31 | US20250263415, Example...)
Affinity DataIC50: 1nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764592(US20250257055, Example 30 | US20250263415, Example...)
Affinity DataIC50: 1.5nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764583(US20250257055, Example 20 | US20250263415, Example...)
Affinity DataIC50: 1.70nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764574(US20250257055, Example 11 | US20250263415, Example...)
Affinity DataIC50: 2.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764580(US20250257055, Example 17 | US20250263415, Example...)
Affinity DataIC50: 2.30nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764591(US20250257055, Example 29 | US20250263415, Example...)
Affinity DataIC50: 2.80nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764597(US20250257055, Example 35 | US20250263415, Example...)
Affinity DataIC50: 5.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764576(US20250257055, Example 13 | US20250263415, Example...)
Affinity DataIC50: 5.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764588(US20250257055, Example 25 | US20250263415, Example...)
Affinity DataIC50: 5.70nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764568(US20250257055, Example 5 | US20250263415, Example ...)
Affinity DataIC50: 6.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764578(US20250257055, Example 15 | US20250263415, Example...)
Affinity DataIC50: 6.10nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764575(US20250257055, Example 12 | US20250263415, Example...)
Affinity DataIC50: 6.30nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764590(US20250257055, Example 27 | US20250263415, Example...)
Affinity DataIC50: 6.80nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM766062(2-{(1'S,3'R)-3'-fluoro-5'-[1-(oxan-4-yl)-1H-pyrazo...)
Affinity DataIC50: 7.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764586(US20250257055, Example 23 | US20250263415, Example...)
Affinity DataIC50: 9nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764589(US20250257055, Example 26 | US20250263415, Example...)
Affinity DataIC50: 9.20nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764587(US20250257055, Example 24 | US20250263415, Example...)
Affinity DataIC50: 9.80nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764585(US20250257055, Example 22 | US20250263415, Example...)
Affinity DataIC50: 11nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM766044(N-[(4-fluorophenyl)methyl]-2-[(1'S)-5'-{1-[1-(oxet...)
Affinity DataIC50: 16nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764571(US20250257055, Example 8 | US20250263415, Example ...)
Affinity DataIC50: 17.2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM766287(US20250263415, Example 2)
Affinity DataIC50: 19nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764569(US20250257055, Example 6 | US20250263415, Example ...)
Affinity DataIC50: 19.8nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764584(US20250257055, Example 21 | US20250263415, Example...)
Affinity DataIC50: 52nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Human)
Johann Wolfgang Goethe University

Curated by ChEMBL
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  53nMAssay Description:Binding affinity to human HAT1 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764579(US20250257055, Example 16 | US20250263415, Example...)
Affinity DataIC50: 53.6nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764581(US20250257055, Example 18 | US20250263415, Example...)
Affinity DataIC50: 58.2nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM764577(US20250257055, Example 14 | US20250263415, Example...)
Affinity DataIC50: 124nMAssay Description:The HAT activity inhibitory ability of HAT inhibitors was evaluated using SensoLyte HAT(p300) Assay Kit (ANASPEC, AS-72172). Specifically, 7.5 μL of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetHistone acetyltransferase type B catalytic subunit(Human)
Johann Wolfgang Goethe University

Curated by ChEMBL
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  183nMAssay Description:Binding affinity to human HAT1 incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM50632831(CHEMBL5406943)
Affinity DataKd:  5.20E+3nMAssay Description:Binding affinity to CM5 sensor chip immobilized C-terminal FLAG tagged full length human HAT1/Rbap46 assessed as dissociation constant by SPR analysi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Human)
Johann Wolfgang Goethe University

Curated by ChEMBL
LigandPNGBDBM50562210(CHEMBL4754158)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of HAT1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM50632831(CHEMBL5406943)
Affinity DataIC50: 1.48E+4nMAssay Description:Inhibition of C-terminal FLAG tagged full length human HAT1/Rbap46 transfected in HEK293F cells using histone H4 peptide as substrate and 4-pentynoyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM50632830(CHEMBL1325863)
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of C-terminal FLAG tagged full length human HAT1/Rbap46 transfected in HEK293F cells using histone H4 peptide as substrate and 4-pentynoyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM50632831(CHEMBL5406943)
Affinity DataIC50: 1.91E+4nMAssay Description:Inhibition of C-terminal FLAG tagged full length human HAT1/Rbap46 transfected in HEK293F cells using histone H4 peptide as substrate and acetyl-CoA ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Human)
Johann Wolfgang Goethe University

Curated by ChEMBL
LigandPNGBDBM50506380(CHEMBL4587968 | US20240122941, Compound 15)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of HAT1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetHistone acetyltransferase type B catalytic subunit(Homo sapiens)
Sumitomo Pharma Co.

US Patent
LigandPNGBDBM50362895(Lactoflavin | RIBOFLAVIN)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of C-terminal FLAG tagged full length human HAT1/Rbap46 transfected in HEK293F cells using histone H4 peptide as substrate and 4-pentynoyl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed